Generics 31

Biosimilars

Medical devices

Nutraceuticals

Filters

Lacosamide manufacturers

31 products found

Filters

31 products found

lacosamide

Tablets, film coated 50 mg, 100mg, 150mg, 200mg

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
Clinical data
Bioequivalence
GMP approvals
EU GMP
Unavailable markets
Iraq, Vietnam

Manufacturer #260

Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

lacosamide

Syrup 10 mg/ml - 465 ml, 200 ml

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Under Development
GMP approvals
EU GMP
Unavailable markets
Portugal, Vietnam

Manufacturer #437

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 11 days

lacosamide

Tablets, film coated 50mg, 100mg, 150mg, 200mg

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Under Development
GMP approvals
EU GMP
Unavailable markets
Portugal, Vietnam

Manufacturer #437

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 11 days

Want to view all 31 products? Create your free account today!

Lacosamide

Lacosamide is a medication used in the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. It is used alone and in combination with other medications to control certain types of seizures in adults and children 4 years of age and older to prevent and control seizures. Lacosamide is in a class of medications called anticonvulsants or antiepileptic drugs. It works by reducing the spread of seizure activity in the brain by decreasing abnormal electrical activity in the brain. Lacosamide is the prescribed in the treatment of Temporal Lobe Epilepsy, Focal Impaired Awareness or Complex Partial Seizures, Secondarily Generalized Seizures or Bilateral Tonic-Clonic Seizure, Focal Aware or Simple Partial Seizure.
Lacosamide the generic name for the brand drug called Vimpat. Schwarz Pharma got FDA approval for clinical use in 2008. UCB Pharma acquired Schwarz Pharma in 2007, and following its approval, Lacosamide has been marketed by UCB Pharma or its partners.

Dosage and forms:

Lacosamide is available in multiple formulations including oral tablets, syrup, and intravenous (IV) infusion. When used with other seizure medicines in adults, Lacosamide usual initial recommended dose starts at 100 mg daily and in some cases, the patients may be started on 200 mg daily and increased weekly. Amongst children, the usual recommended dose for kids between 11 kg and less than 30 kg is 6 mg to 12 mg per kilogram of body weight each day. For kids who weigh between 30 kg and less than 50 kg, the usual standard dose is 4 mg to 8 mg per kilogram of body weight each day. And for kids who weigh more than 50 kg and higher, the usual initial dose is 50 mg, taken twice a day and can be increased as per the Doctor’s discretion.

The cost of Lacosamide:

As of 2020, the consumer has to pay around $823 Vimpat intravenous solution for a supply of 200 mg/20 mL, for a supply of 200 milliliters and 60 tablets of 100mg costs $1054. However, the costs of this medicine are significantly lower in the developing world. In India, the same supply for 60 tablets of 100mg sells for as low as $15.

How does it work?

Brain cells work and talk to each other through electrical discharges. These discharges must fire at a certain frequency to function normally. Sodium channels are like gates of brain cells, as in, they carry electrical activity from one cell to another. Lacosamide actions slow down these electrical discharges in some way or the other. Because its action either turns off or slows down the sodium channels in the brain. Thus the patient finds relief from the seizure and allows the brain cells to recover.

Finding Lacosamide Manufacturers and Suppliers:

The process of finding trusted Lacosamide manufacturers and Lacosamide suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities.
The robust search engine makes it convenient to search for manufacturers and suppliers of Lacosamide. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.